A Novel Mouse Model of Alzheimer's Disease with Chronic Estrogen Deficiency Leads to Glial Cell Activation and Hypertrophy. (28th September 2011)

• Record Type: Journal Article
• Authors: Prat, Annik; Behrendt, Maik; Marcinkiewicz, Edwige; Boridy, Sebastien; Sairam, Ram M.; Seidah, Nabil G.; Maysinger, Dusica
• Other Names: Van Gool Willem A. Academic Editor.
• Is Part Of: Journal of aging research. Volume 2011(2011)
• Publication Date: 2011-09-28
• Subjects: Aging -- Periodicals; Aging -- Research -- Periodicals; 612.6705
• DOI: 10.4061/2011/251517
• Languages: English
• ISSNs: 2090-2204

Abstract

Abstract : The role of estrogens in Alzheimer's disease (AD) involving β -amyloid (A β ) generation and plaque formation was mostly tested in ovariectomized mice with or without APP mutations. The aim of the present study was to explore the abnormalities of neural cells in a novel mouse model of AD with chronic estrogen deficiency. These chimeric mice exhibit a total FSH-R knockout (FORKO) and carry two transgenes, one expressing the β -amyloid precursor protein (APPsw, Swedish mutation) and the other expressing presenilin-1 lacking exon 9 (PS1Δ9). The most prominent changes in the cerebral cortex and hippocampus of these hypoestrogenic mice were marked hypertrophy of both cortical neurons and astrocytes and an increased number of activated microglia. There were no significant differences in the number of A β plaques although they appeared less compacted and larger than those in APPsw/PS1Δ9 control mice. Similar glia abnormalities were obtained in wild-type primary cortical neural cultures treated with letrozole, an aromatase inhibitor. The concordance of results from APPsw/PS1Δ9 mice with or without FSH-R deletion and those with letrozole treatment in vitro (with and without A β treatment) of primary cortical/hippocampal cultures suggests the usefulness of these models to explore molecular mechanisms involved in microglia and astrocyte activation in hypoestrogenic states in the central nervous system.